SCHEMBL2860149

SCHEMBL2860149

CCC(C(=O)OC)c1cc(O)cc(O)c1C(=O)c1ccc(OC)c(O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYNJ2 O15056 1/20 0.51
TUBB4A P04350 1/20 0.46
TUBB P07437 1/20 0.46
TUBA3C P0DPH7 1/20 0.46
TUBA1B P68363 1/20 0.46
TUBA4A P68366 1/20 0.46
TUBB4B P68371 1/20 0.46
TUBB3 Q13509 1/20 0.46
TUBB2A Q13885 1/20 0.46
TUBB8 Q3ZCM7 1/20 0.46
TUBA3E Q6PEY2 1/20 0.46
TUBA1A Q71U36 1/20 0.46
TUBA1C Q9BQE3 1/20 0.46
TUBB6 Q9BUF5 1/20 0.46
TUBB2B Q9BVA1 1/20 0.46
TUBB1 Q9H4B7 1/20 0.46
CYP19A1 P11511 1/20 0.44
PDE4D Q08499 3/20 0.42
PDE4B Q07343 3/20 0.42
PDE4A P27815 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2856271 0.90 TAS1R3 (0.46) SYNJ2CYP19A1MEN1GAAMAPT
SCHEMBL2858308 0.89 SYNJ2 (0.52) SYNJ2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2861256 0.87 CYP3A4 (0.44) SYNJ2MEN1GAAMAPTHPGD
SCHEMBL2861398 0.87 NR1H2 (0.44) SYNJ2MEN1KMT2ANR1H2NR1H3
SCHEMBL2865476 0.86 CYP3A4 (0.46) SYNJ2MAPTHPGDNR1H2NR1H3
SCHEMBL2861765 0.83 NR1H2 (0.41) SYNJ2MEN1GAAMAPTKMT2A
SCHEMBL2860488 0.83 TAS1R3 (0.44) PDE4DPDE4AMEN1MAPTHPGD
SCHEMBL5491546 0.82 SYNJ2 (0.49) SYNJ2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2865026 0.81 LDHA (0.45) SYNJ2MEN1KMT2ANR1H2NR1H3
SCHEMBL2862742 0.80 LMNA (0.48) SYNJ2CYP19A1MEN1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1642880-B1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KIRIN CO LTD (JP) 2013-09-04 EP disclosed
US-7767693-B2 Hsp90 family protein inhibitors KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-08-03 US disclosed
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-10-01 US disclosed
US-7538224-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070032532-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-02-08 US disclosed
EP-1642880-A1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032532-A1 Hsp90 family protein inhibitors HSP90AB1, HSP90B1, HSP90AB2P SYNJ2 4612/4885TUBB4A 2894/4885TUBB 2023/4885
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS HSP90AB1, HSP90B1, HSP90AB2P SYNJ2 4612/4885TUBB4A 2894/4885TUBB 2023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.